Document is current
Any future updates will be listed below
-
Authors
Lorè, Nicola I. https://orcid.org/0000-0001-9159-1632
De Lorenzo, Rebecca
Rancoita, Paola M. V.
Cugnata, Federica
Agresti, Alessandra
Benedetti, Francesco
Bianchi, Marco E.
Bonini, Chiara
Capobianco, Annalisa
Conte, Caterina
Corti, Angelo
Furlan, Roberto
Mantegani, Paola
Maugeri, Norma
Sciorati, Clara
Saliu, Fabio
Silvestri, Laura
Tresoldi, Cristina
,
Farina, Nicola
De Filippo, Luigi
Battista, Marco
Grosso, Domenico
Gorgoni, Francesca
Di Biase, Carlo
Moretti, Alessio Grazioli
Granata, Lucio
Bonaldi, Filippo
Bettinelli, Giulia
Delmastro, Elena
Salvato, Damiano
Magni, Giulia
Avino, Monica
Betti, Paolo
Bucci, Romina
Dumoa, Iulia
Bossolasco, Simona
Morselli, Federica
Ciceri, Fabio
Rovere-Querini, Patrizia
Di Serio, Clelia
Cirillo, Daniela M.
Manfredi, Angelo A.
-
Funding
Funding for this research was provided by:
Ministero della Salute (COVID-2020-12371617)
EHA
- License Information
-
More Information
Article History
Received: 7 June 2021
Accepted: 2 October 2021
First Online: 18 October 2021
Declarations
:
: The COVID-BioB study protocol, compliant with the declaration of Helsinki, was approved by the Hospital Ethics Committee (Protocol No. 34/int/2020) and registered on ClinicalTrials.gov (NCT04318366). All patients signed informed consent.
: All authors have approved the current version of the manuscript.
: The authors declare that they have no competing interests.
